Israel Cancer Research Fund

Haute Residence and Acclaimed Real Estate Broker Myra Nourmand Continue Their Partnership Into Its Ninth Year

Retrieved on: 
Wednesday, February 14, 2024
L.A. Confidential, Social media, Aviva, RELO, Marketing, Woman, Real estate, Cumulus Media Networks, LOS, FOX, Partnership, Associate, HGTV, Haute Living, IDF, ABC, Neon Museum, Radio, Discovery, Rich, Israel Cancer Research Fund, Jewish National Fund, NBC, The Wall Street Journal, House, Variety, Knowledge, First lady, House & Garden, Trust, Los Angeles Business Journal, Residence, Rett syndrome, Fashion design

LOS ANGELES, Feb. 14, 2024 /PRNewswire-PRWeb/ -- Myra Nourmand specializes in marketing and selling luxury properties from Beverly Hills to Malibu. Myra is a role model for success-oriented women. Known as the First Lady of Real Estate in Beverly Hills, she is a high-end producer, having successfully listed and sold properties ranging from $1 million to $60 million. The vast majority of her clients are in the entertainment industry, and she has earned the trust and respect of some of the most high-profile clients. Her level of expertise in the luxury home market comes from her ability to match her client's needs with her knowledge of the inventory.

Key Points: 
  • Haute Residence and acclaimed real estate professional Myra Nourmand continue their successful partnership.
  • LOS ANGELES, Feb. 14, 2024 /PRNewswire-PRWeb/ -- Myra Nourmand specializes in marketing and selling luxury properties from Beverly Hills to Malibu.
  • Myra is the author of "From Homemaker to Breadwinner" part memoir and part real estate handbook for professionals.
  • Myra is a Real Estate Specialist with a reputation for excellence in Listing, Marketing, and Selling high-end properties.

Children's Cancer Research Fund (CCRF) Awards $100,000 Grants to Eight Early-Career Researchers as Childhood Cancer Awareness Month Wraps

Retrieved on: 
Wednesday, September 28, 2022
Israel Cancer Research Fund, University of Rochester, R01, National, Nationwide Children's Hospital, Children's Cancer Research Fund, Gastrointestinal tract, Safety, Virginia Tech, Incidence, Master of Science, University of Minnesota, Disease, Hospital, SMARCAL1, Seattle Children's, Ewing's sarcoma, Obesity, Lutetium (177Lu) oxodotreotide, Government, Benaroya Research Institute, Clinical trial, Cancer, Acute myeloid leukemia, Doctor of Philosophy, Acute lymphoblastic leukemia, Research, University, Research institute, Dana–Farber Cancer Institute, CCRF, Pharmaceutical industry, Medical imaging, Antibiotics, Dietary supplement, MD

MINNEAPOLIS, Sept. 28, 2022 /PRNewswire/ -- Children's Cancer Research Fund (CCRF) recently awarded these eight promising scientists the Emerging Scientist Award, each worth $100,000, to pursue their research in the childhood cancer field:

Key Points: 
  • Emily Heikamp, MD, PhD, MSc, Dana-Farber Cancer Institute, will research the mechanisms that drive NUP98-r acute myeloid leukemia.
  • Jemma Larson, PhD, University of Minnesota, aims to understand the deadly impact of acute Graft-versus-Host Disease in the gastrointestinal tract.
  • At CCRF, we believe scientists early in their careers have inventive approaches that can advance the childhood cancer research field.
  • Since 1981, CCRF donors have funded research that has revolutionized the way childhood cancer is treated worldwide.

Victoria’s Secret and Pelotonia Present Scientific Achievement Awards to Women in Cancer Research

Retrieved on: 
Wednesday, April 13, 2022
VSCO, Drug development, Genetic testing, Secrecy, Athleisure, Woman, Population, Association, Endometrial cancer, Fund, Research, Diagnosis, HC, Investor, Caregiver, Center, Leadership, Organization, GLOBE, Program, Drug resistance, Patient, Risk assessment, Workforce, Israel Cancer Research Fund, Breast, Weill Cornell Medicine, Breast cancer, Female, Carcinogenesis, Organic, American Association for Cancer Research, NYSE, International Agency for Research on Cancer, American Association, Partnership, University, Weill Cornell Medical Center, Defence Scientific Advisory Council, AACR, Therapy, Pharmaceutical industry, Dietary supplement, Birth control, Clothing, Cancer, MD, Martine Piccart, Doctor of Philosophy, Pelotonia

COLUMBUS, Ohio, April 13, 2022 (GLOBE NEWSWIRE) -- Victoria's Secret and impact partner Pelotonia presented five female cancer researchers with scientific achievement awards of $100,000 each at the American Association for Cancer Research (AACR) Annual Meeting this past weekend.

Key Points: 
  • COLUMBUS, Ohio, April 13, 2022 (GLOBE NEWSWIRE) -- Victoria's Secret and impact partner Pelotonia presented five female cancer researchers with scientific achievement awards of $100,000 each at the American Association for Cancer Research (AACR) Annual Meeting this past weekend.
  • We have long supported cancer research, but this particular program accelerating innovation in cancer research for women, by women is a tangible way were bringing to life our brands vision of being a leading advocate for women, said Christy Tostevin, senior vice president of communications and community relations, Victorias Secret.
  • Yet research of womens cancers is historically under-resourced, and there arent enough women driving said research.
  • The Fund will accelerate innovation in cancer research for women, by women.

Rarebase launches a neuroscience drug discovery platform collaborating with 15 rare disease patient organizations

Retrieved on: 
Tuesday, September 14, 2021
Science, Andrew Kerr (festival co-founder), Drug discovery, CEO, FDA, Technology, Genetic testing, Silk, Function, Patient, Gene, STXBP1, Autism, Founder, Disease, Entrepreneurship, Neurodegeneration, Degenerative disease, Multimedia, Israel Cancer Research Fund, PALO, Steel, Lists of diseases, Organization, Oklahoma Medical Research Foundation, Life, Lightning, Pharmaceutical industry

PALO ALTO,Calif., Sept. 14, 2021 /PRNewswire/ --Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function.

Key Points: 
  • PALO ALTO,Calif., Sept. 14, 2021 /PRNewswire/ --Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function.
  • "Function is finally doing justice to how we need to approach finding answers for rare diseases," said Penny Howard.
  • "We're thrilled to be actively collaborating with rare disease patient organizations.
  • "Rarebase is pushing the limits of science and innovating a financial structure that allows patient organizations to directly support drug discovery," said Mike Graglia, the Founder and Managing Director of the SynGAP Research Fund.

Financial Awards by Israel Cancer Association Spawn Significant Research Findings and Advance Studies About Gene-predictors to the Body’s Development of Cancer and Its Response to Traditional Treatments

Retrieved on: 
Thursday, August 22, 2019
Science, Other Science, Research, Oncology, Health, Genetics, Geography of Asia, Western Asia, Cancer, Cancer research, Middle East, Israel, Israel Cancer Research Fund, Canadian Cancer Society

Each year, scientists at leading hospitals universities and institutions in Israel amongst the top in cancer research apply for research funding from Israel Cancer Association.

Key Points: 
  • Each year, scientists at leading hospitals universities and institutions in Israel amongst the top in cancer research apply for research funding from Israel Cancer Association.
  • Bruce S. Koppel, ICA USA Board President said, Israel Cancer Association USA has touched the lives of thousands of cancer patients in Israel (and worldwide) by providing major funding to award winning Israeli cancer researchers.
  • Cancer research in Israel can be done at a third to a quarter of the cost of like research in the United States.
  • Since its inception in 1994, Israel Cancer Association USAs mission has been to fund cancer research in Israel.